Skip to main content
Menu
US
Literature - Publication Review

Ultrasound imaging provides noninvasive 3D views into vascular changes in response to cancer therapy

vega-ultrasound-renal512

Monitoring tumor response to therapy typically relies on changes in tumor volume. However, various functional and molecular changes, including vascular density, occur before any measurable changes in tumor size are observed. Some imaging modalities such as MRI and PET, have been used to predict response to therapy, but high costs, long imaging times, and radiation risks limit their application.

Learn how researchers used ultrasound imaging to measure vascular density in mice to assess the response of renal cell carcinoma tumors to antiangiogenic and Notch inhibition therapies earlier than the gold standard for evaluating tumor volume.

For research use only. Not for use in diagnostic procedures. 

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Ultrasound imaging provides noninvasive 3D views into vascular changes in response to cancer therapy